3 key investor takeaways from the week
Drew Meredith, CFP
April 26, 2022
Here are my three key investor takeaways from a shortened
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Here are my three key investor takeaways from a shortened
The S&P/ASX 200 (ASX:XJO) finished flat on Wednesday as Ramsay
It was another weak day for the S&P/ASX 200 (ASX:
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed
The Cochlear Limited (ASX: COH) share price has bounced this
Australian investors had some respite on Friday, as volatility disappeared
Homegrown medical device company Resmed Inc (ASX: RMD) has updated
The S&P/ASX 200 (ASX:XJO) finished the week and the month
The Resmed CDI (ASX: RMD) share price has launched into
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
